Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Registry for Subjects With Cirrhosis Who Achieve a Sustained Virologic Response Following Treatment With a Sofosbuvir-Based Regimen Without Interferon for Chronic Hepatitis C Infection

NCT02292706 is registered in ClinicalTrials.gov with Gilead Sciences as lead sponsor.

NCT NCT02292706
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02292706 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Registry for Subjects With Cirrhosis Who Achieve a Sustained Virologic Response Following Treatment With a Sofosbuvir-Based Regimen Without Interferon for Chronic Hepatitis C Infection
Lead sponsor
Gilead Sciences
Phase
Observational
Overall status
Terminated
Start date
December 29, 2014
Completion date
December 31, 2021
Enrollment
1,609 (actual)
Sites
138

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis c virus infection